Moderna announced that U.S. authorities have approved its experimental personali...
This week we take a look at FDA’s approval for the first home test kit, how soci...
The FDA is considering granting de novo clearance for a device aimed at treating...
Patients suffering from peripheral arterial disease (PAD) frequently require low...
The Food and Drug Administration (FDA) has cleared Abbott’s laboratory blood tes...
“Maps don’t show you where you will go in life, they show you where you might go...
French drugmaker Servier recently acquired Agios Pharmaceutical’s cancer unit fo...
Two RSV vaccinations targeted toward elders, one from Pfizer and one from GSK, h...
The approval of the combination of Tafinlar and Mekinist is based on the Phase I...
The collaboration will combine the use of new drug targets for the disease from ...
The collaboration will use the LENSai Full Suite of Integrated Intelligence Tech...
One immediate outcome of Silicon Valley Bank’s collapse will be its former clien...
Experts debunk gender-affirming care safety concerns and detail logistical barri...
Vyvgart’s approval is based on the data obtained from the global Phase III ADAPT...
Despite advancing research, clinical data and timely reimbursement are crucial f...
GlobalData analysts detail a rise in risk sharing agreements with pharma compani...
